Navigation Links
Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
Date:1/16/2008

Dr. Ross J. Horsburgh Brings 20 Years of Pharmaceutical and CRO Experience

in Asia/Pacific Region to Key Leadership Role

CINCINNATI, Jan. 16 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced Dr. Ross J. Horsburgh has joined the company as Vice President, Global Clinical Development - Asia/Pacific. In this role, he will lead the company's overall expansion in Asia/Pacific and will provide strategic oversight for its Phase II-III operations in the region, including Melbourne and Sydney, Australia; New Delhi, India; and Beijing, China. In all, Dr. Horsburgh brings 20 years of CRO and pharmaceutical industry experience to Kendle.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"With a population base of nearly 4.0 billion and R&D spending expected to reach $20 billion by 2013, Asia/Pacific is recognized by our customers as one of the more dynamic regions in which to conduct clinical trials," said Dr. Kendle. "Dr. Horsburgh's extensive clinical development experience and familiarity with the Asia/Pacific region will benefit both our customers and Kendle as we execute on our growth strategy for this pivotal market."

Prior to joining Kendle, Dr. Horsburgh was Regional Medical Director, Asia Pacific for AstraZeneca. In this role, he assembled and led a team of 200 individuals across 13 markets. He also served as head of AstraZeneca's internal clinical research organization, responsible for quality assurance, drug safety, talent management and development, input of the Asian view into global product design, and ultimately, submi
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
2. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
3. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Novo Nordisk Appoints New Leader of North American Business
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...I is pleased to announce the launch of its redesig... Denver, Colorado (PRWEB) October 6, 2008 --...customers and target market, OCI is pleased to ann....oci.com. The site features improved content, an e...,“Human Resource, Benefits and http://www.oc...
(Date:10/6/2008).... Candice Lane, a leading physician in anti-aging ...aging, and aesthetic blog, Hormone Health MD Plus,...on not widely availabe among practicing physicians...menopause, menopause, PMS, andropause, thyroid def... and fatigue, and diseases of aging using bioident...
(Date:10/6/2008)...spital Ship Serving in West Africa Receives Access...ey, Texas October 6, 2008 -- www.seamobile.com [Se...of communications services to remote locations, an...xNews channel via satellite to Mercy Ships onboard... The Africa Mercy is the world,s largest non-gover...
(Date:10/6/2008)...therville-based civil litigation and criminal defe.... after jury awarded $3.2 million to plaintiff ear...lle, Maryland ((Lexis Nexis) October 6, 2008 -- At.../ [Miller, Murtha & Psoras] have successfully ... a Maryland welder who was awarded more than $3 mi...
Breaking Medicine News(10 mins):Health News:Information Management Solutions Provider OCI Announces Redesign of Corporate Web Site 2Health News:Candice Lane MD Launches Hormone Health MD Plus: The First Doctor Bioidentical Hormone Blog 2Health News:Candice Lane MD Launches Hormone Health MD Plus: The First Doctor Bioidentical Hormone Blog 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3Health News:Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel 2
... response to the global burden imposed by the wide...nical drug trials involving herbal medicines. //It... are afflicted with the disease. The initiative w...edies in the treatment of AIDS/HIV. About 14 natur...
...growing number of animal and human studies show th... unexpected changes in pain sensitivity, resulting...nse to painful// stimulation) and allodynia (abnor...inful stimulation). Interestingly, prev...
...ofessor Vittorio Demicheli an Italian epidemiologi...involving the use of Mumps, Measles and Rubella (M...e link between MMR vaccination and autism or bowel...ne shots in children’s may cause Autism. This revi...
...searchers say low levels of low density lipoprotei...afe for heart patients who are taking statins.// T...LDL cholesterol from over 200 milligrams/deciliter...o one knows whether such levels are safe. Dr. Chri...
Other Medicine News:Health News:Opioids And Abnormal Pain Perception 2Health News:MMR Vaccination not linked to Autism 2
(Date:10/6/2008)...ent of moderate to severe patients achieved endosc...doscopic remission at Week 10,in data from a 54-we...ege,of Gastroenterology (ACG) Annual Scientific Me...today presented data from a,large, prospective stu...,disease (CD) with a biologic compound. The data p...
(Date:10/6/2008)...- Dendreon Corporation (Nas...ay, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) to ...IMPACT,(IMmunotherapy for Prostate AdenoCarcinoma ... PROVENGE(R) (sipuleucel-T), the Company,s investi...atment of advanced prostate,cancer., Those int...
(Date:10/3/2008)..., New Jersey is the newest study site, PHILADELPH...,s Hospital,of Philadelphia today received a contr...ldren,s Study. Children,s Hospital will manage loc...in Burlington County, New,Jersey. The study is fun...igators anticipate approximately 1,000 families in...
(Date:10/2/2008)...rgent PC clinical success and expanded reimburseme...APOLIS, Oct. 2 /- Uroplasty...of the first patients in a new,randomized, control...Urgent,PC neuromodulation system for the treatment...rgency, urge incontinence and frequency of urinary...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 1Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 2Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 3Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 4Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 5Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 6Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 7Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 8Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 9Biopure Gives Update on Malaysia Joint Venture Discussions 151 1Biopure Gives Update on Malaysia Joint Venture Discussions 151 2Biopure Gives Update on Malaysia Joint Venture Discussions 151 3Many Older Americans Have Active Sex Lives 151 1Many Older Americans Have Active Sex Lives 151 2Many Older Americans Have Active Sex Lives 151 3Many Older Americans Have Active Sex Lives 151 4FDA Approves First Anti Psychotic for Kids 148 1FDA Approves First Anti Psychotic for Kids 148 2FDA Approves First Anti Psychotic for Kids 148 3
...SHINGTON, June 20, 2007 /PRNewswire-USNewswire/ --...n issued the following,statement today after Presi... by vetoing the Stem Cell Research Enhancement Act...ding for life-saving,embryonic stem cell research,...le and passed both the House and Senate with,bipar...
...FORD, England, 20 June 2007 - VASTox plc (AIM: VOX...hat it has been awarded a,grant of £400,000 ...) under the SMARTCymru scheme. The grant,which r...evelopment,work undertaken at VASTox’s Abery...ique skills and expertise of its scientists,based ...
Other Medicine Technology:Dean: President Bush Has Turned His Back on the American People 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: